Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Interventions in Obesity & Diabetes

Pyruvate May be a Novel Intervention of Diabetes

  • Open or CloseFang-Qiang Zhou*

    Fresenius Medical Care, Dialysis Centers in Chicago, USA

    *Corresponding author:Fang-Qiang Zhou, 200 W. Sahara Ave., Unit 604, Las Vegas, NV 89102. Email: fqzh60130@yahoo.com, phone: 1-708-785-3568.

Submission: February 18, 2021Published: March 04, 2021

DOI: 10.31031/IOD.2021.05.000602

ISSN : 2578-0263
Volume5 Issue1

Abstract

Recent advances in pyruvate studies indicate that pyruvate may be a novel therapy in care of diabetes and its organ complications. The major action of pyruvate protection against diabetes may be in rejuvenation of glucose oxidation by preserving glycolysis and reactivating pyruvate dehydrogenase activity in the tricarboxylic acid cycle, reversing the Warburg effect in diabetic glucometabolic disorders. Pyruvate preservation of glucose metabolism plus its beneficial effects, such as anti-hypoxia, -oxidative stress, -acidosis, -apoptosis and -advanced glycation end products and stimulation of insulin secretion, may turn diabetic vicious circle virtuous in initiation and development of diabetic process. This review proposed a novel opinion focused on pyruvate superior biomedical and pharmacological properties in diabetes treatment and experimental and clinical evidence of pyruvate intervention in diabetes. The novel pyruvate modified oral rehydration salt (Pyr-ORS), based on WHO-ORS, may be helpful in the prevention and treatment of diabetes in a large population. Further studies and clinical trials are urgently required.

Keywords:Acidosis; Diabetes; Hypoxia; Oral rehydration salt; Pyruvate

Abbreviations: AGEs: Advanced Glycation End Products; LDH: Lactate Dehydrogenase; PDH: Pyruvate Dehydrogenase; PK: Pyruvate Kinase; TCA: Tricarboxylic Acid; TDD: Total Daily Dose

Get access to the full text of this article